Parsons Capital Management Inc Relmada Therapeutics, Inc. Transaction History

Parsons Capital Management Inc

  • $1.58 Billion
  • Q2 2025

A detailed history of Parsons Capital Management Inc transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Parsons Capital Management Inc holds 163,336 shares of RLMD stock, worth $96,368. This represents 0.01% of its overall portfolio holdings.

Number of Shares
163,336
Previous 163,336 -0.0%
Holding current value
$96,368
Previous $44,000 122.73%
% of portfolio
0.01%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025
SELL
$0.35 - $3.65 $293,775 - $3.06 Million
-839,359 Reduced 83.71%
163,336 $84,000
Q3 2024

Nov 04, 2024
BUY
$2.3 - $4.36 $61,524 - $116,630
26,750 Added 2.74%
1,002,695 $3.25 Million
Q2 2024

Jul 19, 2024
BUY
$2.93 - $4.94 $7,105 - $11,979
2,425 Added 0.25%
975,945 $2.93 Million
Q1 2024

Apr 22, 2024
BUY
$3.1 - $6.8 $73,404 - $161,017
23,679 Added 2.49%
973,520 $4.53 Million
Q4 2023

Jan 22, 2024
SELL
$2.45 - $4.22 $59,390 - $102,297
-24,241 Reduced 2.49%
949,841 $3.93 Million
Q3 2023

Nov 06, 2023
BUY
$2.48 - $3.79 $249,909 - $381,918
100,770 Added 11.54%
974,082 $2.92 Million
Q2 2023

Aug 04, 2023
BUY
$2.22 - $3.54 $335,544 - $535,056
151,146 Added 20.93%
873,312 $2.15 Million
Q1 2023

Apr 17, 2023
BUY
$2.24 - $4.76 $506,042 - $1.08 Million
225,912 Added 45.52%
722,166 $1.63 Million
Q4 2022

Feb 13, 2023
SELL
$2.17 - $35.84 $16,376 - $270,484
-7,547 Reduced 1.5%
496,254 $1.73 Million
Q3 2022

Oct 26, 2022
BUY
$18.3 - $37.02 $457 - $925
25 Added 0.0%
503,801 $18.7 Million
Q2 2022

Jul 29, 2022
BUY
$16.5 - $30.34 $11,550 - $21,238
700 Added 0.14%
503,776 $9.57 Million
Q1 2022

May 02, 2022
SELL
$16.72 - $26.99 $5,617 - $9,068
-336 Reduced 0.07%
503,076 $13.6 Million
Q4 2021

Feb 07, 2022
BUY
$16.93 - $26.82 $515,315 - $816,347
30,438 Added 6.44%
503,412 $11.3 Million
Q3 2021

Nov 09, 2021
BUY
$21.86 - $34.77 $493,205 - $784,480
22,562 Added 5.01%
472,974 $12.4 Million
Q2 2021

Aug 03, 2021
SELL
$29.55 - $39.15 $29,550 - $39,150
-1,000 Reduced 0.22%
450,412 $14.4 Million
Q1 2021

Apr 28, 2021
SELL
$31.52 - $39.28 $6,304 - $7,856
-200 Reduced 0.04%
451,412 $15.9 Million
Q4 2020

Feb 08, 2021
SELL
$29.88 - $39.8 $105,327 - $140,295
-3,525 Reduced 0.77%
451,612 $14.5 Million
Q3 2020

Oct 29, 2020
BUY
$34.42 - $43.78 $36,141 - $45,969
1,050 Added 0.23%
455,137 $17.1 Million
Q2 2020

Aug 10, 2020
BUY
$31.59 - $49.98 $900,694 - $1.43 Million
28,512 Added 6.7%
454,087 $20.3 Million
Q1 2020

May 05, 2020
BUY
$23.78 - $50.12 $1.39 Million - $2.94 Million
58,642 Added 15.98%
425,575 $14.5 Million
Q4 2019

Feb 03, 2020
BUY
$10.1 - $47.18 $3.71 Million - $17.3 Million
366,933 New
366,933 $14.3 Million

Others Institutions Holding RLMD

# of Institutions
50
Shares Held
5.14M
Call Options Held
0
Put Options Held
0
View Full List

About RELMADA THERAPEUTICS, INC.

RLMD Quotes by TradingView
  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $16.9M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Parsons Capital Management Inc Portfolio

Follow Parsons Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Parsons Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email